| Nome |
# |
|
Mortality in the Survival With ORal D-sotalol (SWORD) trial: why did patients die?, file e1f104fa-132f-8c6e-e053-1005fe0aa0dd
|
45
|
|
Linee Guida. Task Force sulla Morte Cardiaca Improvvisa, Società Europea di Cardiologia. Riassunto delle raccomandazioni, file e1f104fa-0f43-8c6e-e053-1005fe0aa0dd
|
43
|
|
How really rare are rare diseases?: the intriguing case of independent compound mutations in the long QT syndrome., file e1f104fa-1149-8c6e-e053-1005fe0aa0dd
|
18
|
|
Comparison of baroreflex sensitivity and heart period variability after myocardial infarction., file e1f104fa-1042-8c6e-e053-1005fe0aa0dd
|
11
|
|
Genotype-Phenotype correlation in the Long QT Syndrome. Gene-specific triggers for life-threatening arrhythmias, file e1f104fa-05f4-8c6e-e053-1005fe0aa0dd
|
5
|
|
Quantitative analysis of T wave abnormalities and their prognostic implications in the idiopathic long QT syndrome., file e1f104fa-104c-8c6e-e053-1005fe0aa0dd
|
5
|
|
Gender and the relationship between ventricular repolarization and cardiac cycle length during 24-h Holter recordings., file e1f104fa-10c2-8c6e-e053-1005fe0aa0dd
|
5
|
|
Electrocardiography first for reducing cot death., file e1f104fa-10cc-8c6e-e053-1005fe0aa0dd
|
5
|
|
Efficacy of permanent pacing in the management of high-risk patients with long QT syndrome., file e1f104fa-132e-8c6e-e053-1005fe0aa0dd
|
5
|
|
Effect of ventricular fibrillation complicating acute myocardial infarction on long-term prognosis: importance of the site of infarction., file e1f104fa-103a-8c6e-e053-1005fe0aa0dd
|
4
|
|
Prevention of life-threatening arrhythmias by pharmacologic stimulation of the muscarinic receptors with oxotremorine., file e1f104fa-1043-8c6e-e053-1005fe0aa0dd
|
3
|
|
Pathophysiology and prevention of atrial fibrillation., file e1f104fa-10d1-8c6e-e053-1005fe0aa0dd
|
3
|
|
Counting heart beats: a peephole into prediction of sudden and nonsudden cardiac death., file e1f104fa-1138-8c6e-e053-1005fe0aa0dd
|
3
|
|
Genetic and molecular basis of cardiac arrhythmias: impact on clinical management.Parts I and II, file e1f104fa-12bc-8c6e-e053-1005fe0aa0dd
|
3
|
|
null, file e1f104fb-71c6-8c6e-e053-1005fe0aa0dd
|
3
|
|
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi005-A from a patient carrying the KCNQ1-R190W mutation, file e1f104fc-377d-8c6e-e053-1005fe0aa0dd
|
3
|
|
Delayed after depolarizations elicited in vivo by left stellate ganglion stimulation., file e1f104fa-11aa-8c6e-e053-1005fe0aa0dd
|
2
|
|
Torsades de Pointes following Acute Myocardial Infarction: Evidence for a Deadly Link with a Common Genetic Variant., file e1f104fa-11c9-8c6e-e053-1005fe0aa0dd
|
2
|
|
Calmodulin mutations associated with recurrent cardiac arrest in infants., file e1f104fa-99b8-8c6e-e053-1005fe0aa0dd
|
2
|
|
Ranolazine in the treatment of atrial fibrillation: Results of the dose-ranging RAFFAELLO (ranolazine in atrial fibrillation following an electrical cardioversion) study, file e1f104fa-f0fc-8c6e-e053-1005fe0aa0dd
|
2
|
|
Cardiac sympathetic denervation 100years later: Jonnesco would have never believed it, file e1f104fb-389e-8c6e-e053-1005fe0aa0dd
|
2
|
|
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi004-A from a carrier of the KCNQ1-R594Q mutation, file e1f104fc-2b7d-8c6e-e053-1005fe0aa0dd
|
2
|
|
Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model, file e1f104fc-31e0-8c6e-e053-1005fe0aa0dd
|
2
|
|
Precision Medicine and cardiac channelopathies: when dreams meet reality, file 0caf473c-0be2-45ea-a6ff-b90a5e603af5
|
1
|
|
Cost-effectiveness of Neonatal ECG as a Screening for Long QT-syndrome: A Decision Analysis Approach., file e1f104fa-0132-8c6e-e053-1005fe0aa0dd
|
1
|
|
Homozygous Deletion in KVLQT1 Associated With Jervell and Lange-Nielsen Syndrome., file e1f104fa-0e33-8c6e-e053-1005fe0aa0dd
|
1
|
|
Spectrum of ST-T-Wave Patterns and Repolarization Parameters in Congenital Long-QT Syndrome. ECG Findings Identify Genotypes., file e1f104fa-0e40-8c6e-e053-1005fe0aa0dd
|
1
|
|
Gene-specific differences in the circadian variation of ventricular repolarization in the long QT syndrome: a key to sudden death during sleep?, file e1f104fa-0e44-8c6e-e053-1005fe0aa0dd
|
1
|
|
Unexpected interaction between beta-adrenergic blockade and heart rate variability before and after myocardial infarction. A longitudinal study in dogs at high and low risk for sudden death., file e1f104fa-10b7-8c6e-e053-1005fe0aa0dd
|
1
|
|
Clinical problem-solving. QT or not QT?, file e1f104fa-10ca-8c6e-e053-1005fe0aa0dd
|
1
|
|
Efficacy of left cardiac sympathetic denervation has an unforeseen side effect: medicolegal complications., file e1f104fa-11c4-8c6e-e053-1005fe0aa0dd
|
1
|
|
Protective effect of vagal stimulation on reperfusion arrhythmias in cats., file e1f104fa-1327-8c6e-e053-1005fe0aa0dd
|
1
|
|
KCNH2-K897T Is a Genetic Modifier of Latent Congenital Long-QT Syndrome., file e1f104fa-14f9-8c6e-e053-1005fe0aa0dd
|
1
|
|
Effects of unilateral stellate ganglion blockade on the arrhythmias associated with coronary occlusion., file e1f104fa-159e-8c6e-e053-1005fe0aa0dd
|
1
|
|
The effects of daily exercise on susceptibility to sudden cardiac death., file e1f104fa-15a2-8c6e-e053-1005fe0aa0dd
|
1
|
|
Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure., file e1f104fa-1aff-8c6e-e053-1005fe0aa0dd
|
1
|
|
Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions., file e1f104fa-1b02-8c6e-e053-1005fe0aa0dd
|
1
|
|
QTc behavior during exercise and genetic testing for the long-QT syndrome., file e1f104fa-1b08-8c6e-e053-1005fe0aa0dd
|
1
|
|
The risk of sudden cardiac death in patients with non-ST elevation acute coronary syndrome and prolonged QTc interval: effect of ranolazine, file e1f104fa-1f2e-8c6e-e053-1005fe0aa0dd
|
1
|
|
Vagal stimulation, through its nicotinic action, limits infarct size and the inflammatory response to myocardial ischemia and reperfusion., file e1f104fa-2b59-8c6e-e053-1005fe0aa0dd
|
1
|
|
Clinical management of catecholaminergic polymorphic ventricular tachycardia the role of left cardiac sympathetic denervation, file e1f104fa-f0ff-8c6e-e053-1005fe0aa0dd
|
1
|
|
Left cardiac sympathetic denervation in patients with heart failure: A new indication for an old intervention?, file e1f104fa-f413-8c6e-e053-1005fe0aa0dd
|
1
|
|
Vox clamantis in deserto. We spoke but nobody was listening: echocardiography can help risk stratification of the long-QT syndrome., file e1f104fa-f504-8c6e-e053-1005fe0aa0dd
|
1
|
|
Autonomic Modulation for the Management of Patients with Chronic Heart Failure, file e1f104fa-f6e7-8c6e-e053-1005fe0aa0dd
|
1
|
|
Rapid recovery of baroreceptor reflexes in acute myocardial infarction is a marker of effective tissue reperfusion, file e1f104fa-facc-8c6e-e053-1005fe0aa0dd
|
1
|
|
Genetic Modifiers for the Long-QT Syndrome: How Important Is the Role of Variants in the 3′ Untranslated Region of KCNQ1?, file e1f104fb-1eb9-8c6e-e053-1005fe0aa0dd
|
1
|
|
The KCNH2-IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by Long QT Syndrome type 2, file e1f104fb-20c1-8c6e-e053-1005fe0aa0dd
|
1
|
|
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes, file e1f104fb-25fb-8c6e-e053-1005fe0aa0dd
|
1
|
|
Clinical Aspects of Type 3 Long-QT Syndrome: An International Multicenter Study., file e1f104fb-3c3d-8c6e-e053-1005fe0aa0dd
|
1
|
|
Multiscale complexity analysis of the cardiac control identifies asymptomatic and symptomatic patients in long QT syndrome type 1., file e1f104fb-4295-8c6e-e053-1005fe0aa0dd
|
1
|
|
Identification of Cadherin 2 (CDH2) Mutations in Arrhythmogenic Right Ventricular Cardiomyopathy., file e1f104fb-4434-8c6e-e053-1005fe0aa0dd
|
1
|
|
Genotype-Phenotype Correlation in Induced Pluripotent Stem Cell (iPSC) Derived Cardiomyocytes Carrying Calmodulin Mutations, file e1f104fb-4f9c-8c6e-e053-1005fe0aa0dd
|
1
|
|
From patient-specific induced pluripotent stem cells to clinical translation in long QT syndrome Type 2, file e1f104fc-2b04-8c6e-e053-1005fe0aa0dd
|
1
|
|
Long QT Syndrome modelling with cardiomyocytes derived from human-induced pluripotent stem cells, file e1f104fc-3588-8c6e-e053-1005fe0aa0dd
|
1
|
|
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi007-A from a Long QT Syndrome type 1 patient carrier of two common variants in the NOS1AP gene, file e1f104fc-38b5-8c6e-e053-1005fe0aa0dd
|
1
|
| Totale |
210 |